Avidity Biosciences (RNA)
(Real Time Quote from BATS)
$46.16 USD
+1.04 (2.31%)
Updated Jul 22, 2024 03:05 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Earnings News For RNA
-
Avidity Biosciences Reports First Quarter 2024 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Misses Revenue Estimates
-
Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
-
Avidity Biosciences Reports Third Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Second Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports First Quarter 2023 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Fourth Quarter and Year-End 2022 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Tops Revenue Estimates
-
Avidity Biosciences Reports Third Quarter 2022 Financial Results and Recent Highlights
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Lags Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
-
Avidity Biosciences, Inc. (RNA) Reports Q1 Loss, Tops Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Reports Q4 Loss, Lags Revenue Estimates
-
Avidity Biosciences, Inc. (RNA) Reports Q3 Loss, Tops Revenue Estimates
-
Earnings Preview: Avidity Biosciences, Inc. (RNA) Q3 Earnings Expected to Decline
-
Avidity Biosciences, Inc. (RNA) Reports Q2 Loss, Tops Revenue Estimates
-
Will Avidity Biosciences, Inc. (RNA) Report Negative Q2 Earnings? What You Should Know